Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer.
about
Human skin wounds: a major and snowballing threat to public health and the economy.Spatial mapping by imaging mass spectrometry offers advancements for rapid definition of human skin proteomic signatures.Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisProteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.Detection of differentially expressed basal cell proteins by mass spectrometryEmerging targets for the treatment of scleroderma.Apoptosis modulation as a promising target for treatment of systemic sclerosis.The mitochondrial proteome: a dynamic functional program in tissues and disease states.A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related FibrosisHistopathological cutaneous alterations in systemic sclerosis: a clinicopathological studyConnective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro.Biomarkers in systemic sclerosis.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.New insights into the role of oxidative stress in scleroderma fibrosis.Genomics and proteomics: Applications in autoimmune diseases.Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.A qualitative and quantitative proteomic study of human microdialysate and the cutaneous response to injury.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Systematic approach to understanding the pathogenesis of systemic sclerosis.Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1.Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.IL-17 and related cytokines involved in systemic sclerosis: Perspectives.CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma.Editorial: genomic advances in systemic sclerosis: it is time for precision.
P2860
Q30227432-70A419A3-2B69-411C-9D9C-414D680A2CBDQ30465135-D0E30E3C-078C-4C48-96DF-0EA5EBA5C86DQ30845649-745B8C65-9E7B-4128-828D-4240107BB596Q33665990-925CB73E-844A-4DAC-B777-5EC1C118D7D0Q33697789-784150AD-AFFE-45C1-95FF-308CAD2AA190Q34270856-B9112B78-DABB-467F-B598-3B22A0D1B39AQ35207610-82EC6285-8638-4EB3-AE0A-00512401F960Q35532033-60B808D1-2D07-4244-A9D8-3913F119F604Q35587696-3C8654B6-B1C0-495E-AFA3-1DE42D866FA4Q35620376-8B499045-C705-4A2C-9AC7-7D03B0339C09Q36903759-6E077067-D3FC-414C-A4C9-0B319BC09FA1Q37730018-8FE55782-0B33-4051-A7EF-D2283B6ECE10Q37830007-425CF5C4-C33F-4495-9BB4-BD0FF7671CB2Q38026841-FCA61D19-92E4-4FFD-A87F-454DE5479306Q38066181-F5E49AAC-0EAC-46D1-82FB-D4E6F4E9C941Q38156227-9FE694FA-F623-457E-B563-26FB8FFBD105Q38211968-78291C2D-629B-479A-8319-53AE9FFCEA22Q38502687-93E95EDA-8F28-4C13-BB20-7CD1A8B00F8BQ38828584-ACCB0655-FCBE-4A38-85CA-F030E8698D54Q39029340-E583382D-0C0B-4959-9E7E-D282379C332EQ40491370-07A5A2F9-BD3D-4E56-99F2-9AE8ADC0D078Q44449871-B77238D4-8A18-41AB-A5E9-27493EACE2CCQ47400242-1B8A9298-483A-4274-8887-204FE289FD48Q47774368-525206A3-EAA7-4E92-B962-9CBD152E331FQ50494687-511D9371-6B96-4EE6-8BAB-613AD95F90EAQ52841896-D524EE9E-577D-437D-B869-A227E16FF36EQ53396252-59D40E9E-538A-480D-993D-D1210A300443
P2860
Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@en
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@nl
type
label
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@en
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@nl
prefLabel
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@en
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@nl
P2093
P2860
P356
P1433
P1476
Proteomic analysis of sclerode ...... otype of epidermal cell layer.
@en
P2093
C P Denton
R Stratton
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEN370
P577
2008-10-01T00:00:00Z